Structure (1 Structure)
Dapiprazole
Product Images NDC 53020-265
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapiprazole (NDC 53020-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baradaina, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel Container Label (Spl Image Container Label)
This is information about an ophthalmic solution medication containing dapiprazole hydrochloride and mannitol. It should be stored between 20°C to 25°C and once the diluent is added, it should be dissolved before dispensing. There are inactive ingredients listed in the carton. The medication should be dispensed within 21 days of opening, and the vial should be discarded after that. The medication is manufactured for Baradaina, LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
